Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Result of AGM

2 May 2024 13:31

RNS Number : 0491N
Maven Income and Growth VCT 3 PLC
02 May 2024
Β 

Β 

Maven Income and Growth VCT 3 PLC (the Company)

Result of Annual General Meeting

Β 

At the Annual General Meeting of the Company held at Maven Capital Partners UK, LLP, 6th Floor, Saddlers House, 44 Gutter Lane, London, EC2V 6BR on Thursday 2 May 2024 at 11.30 am, all of the Resolutions put to the Meeting were passed.

Β 

At the record date for the Annual General Meeting, being 30 April 2024, the total number of voting rights in the Company stood at and the total shares in issue were 121,551,302. The Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 7,433,772 shares and that the number of proxy votes lodged for each Resolution were as follows:

Β 

Β 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Directors' Report and audited Financial Statements

7,189,255

190,851

48,630

5,036

7,433,772

2

To approve the Directors' Remuneration Report

6,625,068

230,423

484,545

93,736

7,433,772

3

To approve a final dividend payment

7,231,938

176,701

20,097

5,036

7,433,772

4

To re-elect David Allan as a Director

7,102,738

235,423

58,479

37,132

7,433,772

5

To re-elect Bill Nixon as a Director

7,102,239

235,423

75,725

20,385

7,433,772

6

To re-elect Keith Pickering as a Director

Β 

7,088,783

235,423

89,181

20,385

7,433,772

7

To elect David Priseman as a Director

7,053,865

235,423

74,581

69,903

7,433,772

8

To re-appoint Johnston Carmichael LLP as Auditor

6,841,261

226,962

360,513

5,036

7,433,772

9

To authorise the Directors to fix the remuneration of the Auditor

7,148,039

226,962

53,735

5,036

7,433,772

10

To authorise the Directors to allot new shares

6,734,766

212,812

401,545

84,649

7,433,772

11

To authorise disapplication of pre-emption rights

6,436,387

225,922

672,567

98,896

7,433,772

12

To authorise the Company to purchase its own shares

6,581,823

225,922

614,889

11,138

7,433,772

13

To allow a General Meeting to be called on not less than 14 days' notice

6,871,359

253,045

283,379

25,989

7,433,772

Β 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct3.

Β 

A copy of the Resolutions passed at the 2024 AGM have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.

Β 

Β 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

2 May 2024

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RAGQKBBNBBKDKPK
Date   Source Headline
20th May 202610:00 amRNSAdmission of Further Securities to Trading
15th May 202610:05 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:35 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20267:00 amRNSTransaction in Own Shares
30th Apr 20261:30 pmRNSResult of AGM
30th Apr 202610:54 amRNSAdmission of Further Securities to Trading
29th Apr 202612:28 pmRNSIssue of Equity
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:19 amRNSAdmission of Further Securities to Trading
14th Apr 202611:07 amRNSIssue of Equity
8th Apr 20269:28 amRNSAdmission of Further Securities to Trading
25th Mar 202610:54 amRNSAdmission of Further Securities to Trading
24th Mar 20265:32 pmRNSAnnual Financial Report
24th Mar 202612:11 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSNet Asset Value(s)
27th Feb 20265:01 pmRNSTransaction in Own Shares
27th Feb 20267:00 amRNSUnaudited NAV and Dividend Declaration
18th Feb 20264:52 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:05 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:02 amRNSDirector/PDMR Shareholding
17th Feb 202611:00 amRNSDirector/PDMR Shareholding
17th Feb 202610:55 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:03 amRNSAdmission of Further Securities to Trading
16th Jan 20269:42 amRNSIssue of Equity
14th Jan 20262:35 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202510:20 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20254:47 pmRNSResult of General Meeting
28th Oct 20254:24 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:08 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:13 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:30 pmRNSHalf-year Report
22nd Jul 20254:49 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:46 pmRNSStatement re Unaudited NAV and Interim Dividend
15th May 20253:57 pmRNSTransaction in Own Shares
9th May 20259:54 amRNSDirector/PDMR Shareholding
9th May 20259:51 amRNSIssue of Equity
6th May 202511:53 amRNSIssue of Equity
2nd May 20251:11 pmRNSAudited NAV - Dividend Investment Scheme
1st May 20253:15 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:17 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.